The stock's rise snapped a three-day losing streak.

Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared ...

Spire Wealth Management lessened its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange ...

Edwards Lifesciences Corp. closed 26.14% below its 52-week high of $96.12, which the company reached on March 28th.

U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...

Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been given a consensus rating of “Hold” by the twenty-six ratings firms that are presently covering the stock, Marketbeat Ratings reports. One ...

In this article we are going to estimate the intrinsic value of Edwards Lifesciences Corporation ( NYSE:EW) by taking the forecast future cash flows of the company and discounting them back to today's ...

Masimo Corp., an Irvine-based medical device maker amid an executive upheaval, said it has “terminated the employment” of Tom ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.